Q1 FY27 revenue up 26% to Rs 614 Cr, PAT up 44.6% to Rs 55 Cr
AGARWALEYE · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
On the reaction day the stock moved 2.5 pts more than Nifty Microcap 250 and 2.8 pts more than its Hospital peers, over the same two closes: a difference in percentage points, not a measure of what the filing did.
Minute windows have no benchmark: there is no intraday index history to compare against.
Board approved Q1 FY27 results on Aug 4, 2026. Revenue from Operations rose 26% YoY to Rs 614 Cr; total income up 23.9% to Rs 620 Cr. EBITDA grew 25.2% to Rs 177 Cr with margin of 28.5%. PAT jumped 44.6% to Rs 55 Cr. Performed 91,082 surgeries and added 18 new facilities, taking network to 304. Also approved S.R. Batliboi as Statutory Auditors till 20th AGM, KPMG as Internal Auditors, and new step-down subsidiary in Nigeria.
Strong growth across all metrics with record network expansion; positive for shareholders, new subsidiary signals overseas expansion